Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review
Journal for ImmunoTherapy of Cancer · 2025-04 · 13 (4) · e010658
DOI: 10.1136/jitc-2024-010658 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 09.04.2025. Verfasst von Gils Roex und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, High-Throughput Screening Assays. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, Deshpande Center for Technological Innovation, Massachusetts Institute of Technology, 2020 Gilead BeLux fellowship.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)-T-cell therapy has been highly successful in the treatment of B-cell hematological malignancies. CARs are modular synthetic molecules that can redirect immune cells towards target cells with antibody-like specificity. Despite their modularity, CARs used in the clinic are currently composed of a limited set of domains, mostly derived from IgG, CD8α, 4-1BB, CD28 and CD3ζ. The current low throughput CAR screening workflows are labor-intensive and time-consuming, and lie at the basis of the limited toolbox of CAR building blocks available. High throughput screening methods facilitate simultaneous investigation of hundreds of thousands of CAR domain combinations, allowing discovery of novel domains and increasing our understanding of how they behave in the context of a CAR. Here we review the growing body of reports that employ these high throughput screening and computational methods to advance CAR design. We summarize and highlight the important differences between the different studies and discuss their limitations and future considerations for further improvements. In conclusion, while still in its infancy, high throughput screening of CARs has the capacity to vastly expand the CAR domain toolbox and improve our understanding of CAR design. This knowledge could be foundational for translating CAR therapy beyond hematological malignancies and push the frontiers in personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Singapore-MIT Alliance for Research and Technology Centre, Singapore.
- Center for Cell Therapy and Regenerative Medicine, University Hospital Antwerp, Edegem, Belgium.
- Ragon Institute of Mass General MIT and Harvard, Cambridge, Massachusetts, USA.
Förderung
- Fonds Wetenschappelijk Onderzoek
- Deshpande Center for Technological Innovation, Massachusetts Institute of Technology
- 2020 Gilead BeLux fellowship
- Pew-Stewart Scholarship
- National Science Foundation Graduate Research Fellowship Program
- Methusalem financing program from the Flemish Government to the University of Antwerp
- Koch Institute Frontier Research Program
- Packard Fellowship
Zitieren
APA
Roex, G., Gordon, K. S., Lion, E., Birnbaum, M. E., & Anguille, S. (2025). Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review. Journal for ImmunoTherapy of Cancer, 13(4), e010658. https://doi.org/10.1136/jitc-2024-010658
Vancouver
Roex G, Gordon KS, Lion E, Birnbaum ME, Anguille S. Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review. Journal for ImmunoTherapy of Cancer. 2025;13(4):e010658. doi:10.1136/jitc-2024-010658
BibTeX
@article{Roex2025,
author = {Roex, Gils and Gordon, Khloe S and Lion, Eva and Birnbaum, Michael E and Anguille, Sébastien},
title = {Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
volume = {13},
number = {4},
pages = {e010658},
doi = {10.1136/jitc-2024-010658}
}
EUVIMED